# Correction: Si et al. Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics 2020, 12, 1079

**Authors:** Yingnan Si, JiaShiung Guan, Yuanxin Xu, Kai Chen, Seulhee Kim, Lufang Zhou, Renata Jaskula-Sztul, X. Margaret Liu

PMC · DOI: 10.3390/pharmaceutics17101317 · Pharmaceutics · 2025-10-11

## Full-text entities

- **Diseases:** Neuroendocrine Cancer (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12566635/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12566635/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12566635/full.md

---
Source: https://tomesphere.com/paper/PMC12566635